Novel Metastatic Strategies Gain Traction

Andrew D. Smith
Published: Tuesday, Oct 15, 2019
Ralph R. Weichselbaum, MD, of the Ludwig Center for Metastasis Research at the University of Chicago

Ralph R. Weichselbaum, MD

Emboldened by strong evidence from a mounting number of positive trials, investigators are growing confident that localized therapy in oligometastatic disease across cancers may soon lead to a new staging system and become standard of care (SOC). The tasks ahead are to learn more about why some patients respond better than others and to improve patient selection.

Figure 1. Inefficient Metastatic Process Provides A Window For Localized Curative Therapy1

Figure 1. Inefficient Metastatic Process Provides A Window For Localized Curative Therapy

Figure 2. Goals of Localized Therapy Oligometastatic Disease3

Figure 2. Goals of Localized Therapy Oligometastatic Disease
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x